Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
This trial was conducted in Russian Federation. This trial aimed for a comparison of the
effect on glycemic control in subjects with type 2 diabetes of three different treatment
regimens: biphasic insulin aspart 30 thrice daily, biphasic insulin aspart 30 twice daily in
combination with metformin and treatment with oral anti-diabetic drugs.